chr5-145859900-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001080516.2(GRXCR2):c.580G>A(p.Glu194Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000113 in 1,580,056 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001080516.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRXCR2 | NM_001080516.2 | c.580G>A | p.Glu194Lys | missense_variant | 3/3 | ENST00000377976.3 | NP_001073985.1 | |
GRXCR2 | XM_017009708.2 | c.292G>A | p.Glu98Lys | missense_variant | 3/3 | XP_016865197.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRXCR2 | ENST00000377976.3 | c.580G>A | p.Glu194Lys | missense_variant | 3/3 | 2 | NM_001080516.2 | ENSP00000367214 | P1 | |
GRXCR2 | ENST00000639411.1 | c.175G>A | p.Glu59Lys | missense_variant | 4/4 | 5 | ENSP00000491860 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000896 AC: 20AN: 223170Hom.: 0 AF XY: 0.000133 AC XY: 16AN XY: 119984
GnomAD4 exome AF: 0.000107 AC: 153AN: 1427894Hom.: 0 Cov.: 31 AF XY: 0.000117 AC XY: 83AN XY: 706802
GnomAD4 genome AF: 0.000164 AC: 25AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2023 | The c.580G>A (p.E194K) alteration is located in exon 3 (coding exon 3) of the GRXCR2 gene. This alteration results from a G to A substitution at nucleotide position 580, causing the glutamic acid (E) at amino acid position 194 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Autosomal recessive nonsyndromic hearing loss 101 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 10, 2022 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 17, 2023 | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 194 of the GRXCR2 protein (p.Glu194Lys). This variant is present in population databases (rs367826984, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with GRXCR2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1450670). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at